PH Roundtable

Advances in Pulmonary Hypertension

¹ 

关键词: Cardiology;    Lifestyle Issues;    ";    out of proportion";    pulmonary hypertension;    WHO Group 1- Pulmonary Arterial Hypertension;    WHO Group 2- PH owing to left heart disease (left heart failure);    WHO Group 3- Pulmonary hypertension owing to lung disease;    /or hypoxia;    Surgical Interventions;    Mechanical Assist Devices;    symptoms;    Research;    Exercise;    Cardiopulmonary rehabilitation;    Sleep disordered breathing;    nitric oxide;    Diuretics;    Indicators of diastolic dysfunction;    Non-invasive estimate of PVR;    Pulmonary vascular resistance;    pulmonary artery pressure;    exercise hemodynamic testing;    6-Minute Walk Test;    Transplantation;    Preserved ejection fraction;    endothelial proliferation;    endothelial dysfunction;    tricuspid regurgitation;    edema;    Functional Class;    patient-reported outcomes;    clinical trial endpoints;    CME;    Classification;    Epidemiology;   

DOI  :  

学科分类：医学（综合）

来源: Pulmonary Hypertension Association

【 摘 要 】

A panel of experts convened by telephone on April 20, 2011 to discuss their experiences and recommendations regarding diagnosis and management of patients with Group 2 PH. The conversation was facilitated by Myung Park, MD, Associate Professor of Medicine and Director, Pulmonary Vascular Disease Program, Division of Cardiology at University of Maryland School of Medicine and guest editor of this issue. The participants were Rene Alvarez, MD, Associate Professor of Medicine and Director, Advanced Heart Failure/Pulmonary Hypertension Outreach Program, University of Pittsburgh School of Medicine; Teresa De Marco, MD, Professor of Medicine, Director, Heart Failure and Pulmonary Hypertension Program and Director, Heart Transplantation, University of California San Francisco Medical Center; Marc Semigran, MD, Medical Director of the Heart Failure and Cardiac Transplant Program at the Massachusetts General Hospital Center and Associate Professor of Medicine at Harvard Medical School; and Ivan Robbins, MD, Assistant Professor of Medicine and Director, Lung Transplant Program, Vanderbilt University Medical Center.

【 授权许可】

All Rights reserved